| S01ED51 |
Dorzolamide, Timolol |
Duokopt |
Eye drops, solution |
20 mg/ml+5 mg/ml – 10 ml |
|
1 |
Laboratoires Thea, Франция |
1 |
ml |
- |
43.42 |
2.528 |
25.28 |
50% |
12.64 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-10568/12.10.2016; НСР-14891/25.01.2018 |
02.03.2018 |
|
|
Активен |
15438 |
| S01ED51 |
Dorzolamide, Timolol |
OFTIDORIX |
Eye drops, solution |
20 mg/ml + 5 mg/ml - 5 ml |
mg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1 |
ml |
- |
12.64 |
2.528 |
12.64 |
50% |
6.32 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-6440/12.06.2015 допуска предварително изпълнение |
16.06.2015 |
|
|
Активен |
1159 |
| S01ED51 |
Dorzolamide, Timolol |
OFTIDORIX |
Eye drops, solution |
20 mg/ml + 5 mg/ml - 5 ml |
mg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1 |
ml |
- |
12.64 |
2.672 |
13.36 |
50% |
6.68 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
КЦРР-300/15.03.2012 г.; корекц.КЦРР-425/19.04.2012 г; НСР-2355/21.01.2014; НСР-5868/20.03.2015 (допуска предварително изпълнение) |
02.04.2015 |
|
|
Заличен |
1159 |
| S01ED51 |
Dorzolamide, Timolol |
Oftidorix PF |
Eye drops, solution |
20 mg/ml+5 mg/ml-5 ml |
mg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
1 |
ml |
- |
29.32 |
2.528 |
12.64 |
50% |
6.32 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-12003/20.03.2017 |
02.05.2017 |
|
|
Активен |
15631 |
| S01ED51 |
Pilocarpine hydrochloride/Timolol maleate |
S01ED51 Pilocarpine hydrochloride/Timolol maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S01ED51 |
Pilocarpine, Timolol |
FOTIL |
Eye drops, solution |
20 mg/5 mg/ml - 5 ml |
|
1 |
Santen Oy, Финландия |
1 |
ml |
- |
8.26 |
1.652 |
8.26 |
50% |
4.13 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 16/24,06,2009; №40/27.08.2009 |
|
08.09.2012 |
|
Активен |
436 |
| S01ED51 |
Pilocarpine, Timolol |
FOTIL FORTE |
Eye drops, solution |
40 mg/5 mg/ml - 5 ml |
|
1 |
Santen Oy, Финландия |
1 |
ml |
- |
9.12 |
1.824 |
9.12 |
50% |
4.56 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№16/24,06,2009 г.
№40/27.08.2009 г |
|
08.09.2012 |
|
Активен |
437 |
| S01ED51 |
Tafluprost, timolol |
S01ED51 Tafluprost, timolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S01ED51 |
Tafluprost, timolol |
Taptiqom |
Eye drops, solution |
15mcg/ml + 5mg/ml - 0.3 ml |
|
30 single dose container |
Santen Oy, Финландия |
1 |
single dose |
- |
44.11 |
1.32213 |
39.66 |
50% |
19.83 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-14726/21.12.2017 предварително изпълнение; НСР-16692/30.08.2018 |
02.10.2018 |
|
|
Активен |
15499 |
| S01EE01 |
Latanoprost |
S01EE01 Latanoprost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S01EE01 |
Latanoprost |
Akistan |
Eye drops, solution |
50mcg/ml- 2,5ml |
mcg |
1 |
Pharmaselect International Beteiligungs GmbH, Австрия |
0.1 |
ml |
- |
13.92 |
0.2744 |
6.86 |
50% |
3.43 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-597/23.07.2013; НСР-3259/14.04.2014.; НСР-6419/12.06.2015.; Протокол №225/25.05.2017 |
02.07.2017 |
|
|
Активен |
2756 |
| S01EE01 |
Latanoprost |
Glautan |
Eye drops, solution |
50 mcg/ml-2.5 ml |
mcg |
1 |
Софарма АД, България |
0.01 |
mg |
- |
11.1 |
0.6136 |
7.67 |
50% |
3.84 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
КЦРР-2079/24.01.2013 г; НСР-2615/03.02.2014; НСР-8394/07.03.2016 |
02.04.2016 |
|
|
Заличен |
2507 |
| S01EE01 |
Latanoprost |
Latalux |
Eye drops, solution |
50 micrograms/ml-2.5ml |
mcg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
0.1 |
ml |
- |
11 |
0.2744 |
6.86 |
50% |
3.43 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 162/ 20.04.2011; КЦРР-1121/02.08.2012 г.; НСР-2357/21.01.2014.; HCP-7527/19.11.2015.; Протокол №225/25.05.2017; НСР-13102/06.07.2017 |
02.08.2017 |
08.09.2012 |
|
Активен |
1314 |
| S01EE01 |
Latanoprost |
Latanoprost Actavis |
Eye drops, solution |
50 mcg/ml - 2,5 ml |
|
1 |
Actavis Group PTC ehf., Исландия |
0.1 |
ml |
- |
6.86 |
0.2744 |
6.86 |
50% |
3.43 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 70/ 19.04.2010; HCР-471/09.07.2013; НСР-3143/26.03.2014; Протокол №225/25.05.2017; НСР-12953/15.06.2017 |
02.07.2017 |
08.09.2012 |
|
Активен |
2631 |
| S01EE01 |
Latanoprost |
Monoprost |
Eye drops, solution |
50mcg/ml in single dose -0,2 ml |
mcg |
30 (6x5) |
Laboratoires Thea, Франция |
0.1 |
ml |
- |
22.81 |
0.2744 |
16.46 |
50% |
8.23 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-487/11.07.2013; НСР-3197/07.04.2014; НСР-6229/21.05.2015; НСР-10332/15.09.2016; НСР-14892/25.01.2018 |
02.03.2018 |
|
16.11.2013 |
Активен |
2697 |
| S01EE01 |
Latanoprost |
UNILAT |
Eye drops, solution |
50 mcg/ml - 2,5 ml |
mcg |
1 |
Unimed Pharma spol.s.r.o., Словакия |
0.1 |
ml |
- |
11.92 |
0.2744 |
6.86 |
50% |
3.43 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 120/ 09.12.2010; КЦРР-2383/21.02.2013 г; НСР-2430/21.01.2014; НСР-5900/27.03.2015; НСР-9475/09.06.2016; Протокол №225/25.05.2017; НСР-13894/25.09.2017; НСР-17361/30.11.2018 |
02.01.2019 |
08.09.2012 |
|
Активен |
3703 |
| S01EE01 |
Latanoprost |
Xalatan |
Eye drops, solution |
50 mcg/ml - 2,5 ml |
mcg |
1 |
Pfizer Europe MA EEIG, Белгия |
0.1 |
ml |
- |
13.5 |
0.2744 |
6.86 |
50% |
3.43 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 24/31.07.2009 № 51/ 18.02.2010 №40/27.08.2009; НСР-2331/13.01.2014.; НСР-8977/14.04.2016.; НСР-10375/26.09.2016 допуска се предварително изпълнение; Протокол №225/25.05.2017; НСР-17469/13.12.2018 |
02.01.2019 |
08.09.2012 |
16.11.2013 |
Активен |
2423 |
| S01EE03 |
Bimatoprost |
S01EE03 Bimatoprost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S01EE03 |
Bimatoprost |
Glabrilux 0.3 mg/ml |
Eye drops, solution |
0.3 mg/ml - 3 ml |
mg |
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
0.1 |
ml |
- |
23.26 |
0.77533 |
23.26 |
50% |
11.63 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-3027/21.03.2014; НСР-6552/24.06.2015; НСР-6880/30.07.2015 |
02.09.2015 |
|
|
Заличен |
2654 |
| S01EE03 |
Bimatoprost |
LUMIGAN |
Eye drops, solution |
0,1 mg/ml - 3 ml |
|
1 |
Allergan Pharmaceuticals, Ирландия |
0.1 |
ml |
- |
27.83 |
0.92767 |
27.83 |
50% |
13.92 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
КЦРР-2409/21.02.2013 г.; НСР-852/07.08.2013; НСР-3499/16.05.2014; КП-379/28.09.2015 и НСР-6773/23.07.2015; НСР-9633/23.06.2016 г.; Прот. № 210/09.02.2017; Протокол №225/25.05.2017; НСР-16581/24.08.2018 |
02.10.2018 |
|
|
Активен |
2836 |
| S01EE03 |
Bimatoprost |
LUMIGAN |
Eye drops, solution |
0,3 mg/ml - 3 ml |
mg |
1 |
Allergan Pharmaceuticals, Ирландия |
0.1 |
ml |
- |
32.04 |
0.79167 |
23.75 |
50% |
11.88 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№ 83/ 27.05.2010; КЦРР-2772/20.03.2013 г.; НСР-852/07.08.2013; НСР-5710/18.02.2015. |
16.03.2015 |
08.09.2012 |
|
Заличен |
1805 |
| S01EE03 |
Bimatoprost |
Vizibim |
Eye drops, solution |
0.3 mg/ml-3 ml |
|
1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
0.1 |
ml |
- |
31.97 |
0.92767 |
27.83 |
50% |
13.92 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-11741/17.02.2017; Протокол №225/25.05.2017; НСР-16073/05.07.2018 |
02.10.2018 |
|
|
Активен |
15617 |
| S01EE04 |
Travoprost |
S01EE04 Travoprost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S01EE04 |
Travoprost |
Bondulc |
Eye drops, solution |
40 mcg/ml - 2.5ml |
mg |
1 |
Actavis Group PTC ehf., Исландия |
0.1 |
ml |
- |
14.1 |
0.564 |
14.1 |
50% |
7.05 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
НСР-4969/29.10.2014; НСР-7808/28.12.2015; Протокол № 225/25.05.2017; НСР-17005/12.10.2018 |
02.11.2018 |
|
|
Заличен |
3315 |
| S01EE04 |
Travoprost |
Travatan |
Eye drops, solution |
40 mcg/ml - 2.5ml |
mg |
1 |
Novartis Europharm Limited, Ирландия |
0.1 |
ml |
- |
24.62 |
0.7396 |
18.49 |
50% |
9.24 |
|
H40.0,H40.1,H40.2,H40.5,H40.6 |
№19/08,07,2009, № 51/ 18.02.2010, №40/27.08.2009; КЦРР-1206/13.08.2012 г.; НСР-1759/21.11.2013; НСР-4592/15.09.2014; НСР-7467/12.11.2015; Протокол № 225/25.05.2017; НСР-13261/20.07.2017; НСР-16317/27.07.2018; НСР-16933/04.10.2018 |
02.11.2018 |
08.09.2012 |
|
Активен |
3207 |